Cervical Cancer
Conditions
Interventions
Observation group:Paclitaxel + lobaplatin
Control group:Paclitaxel +cisplatin
Sponsors
Guizhou Cancer Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Voluntarily participate and sign informed consent; 2. squamous cell carcinoma or adenocarcinoma confirmed Histologically,age between 18 and 70 years; 3. Tumor lesions can be measured by gynecological examination, CT / MRI measurement; 4. KPS=70, survival expectations=6months and Blood, liver and kidney function normal; 5. The treatment is the first course of treatment (no pelvic radiotherapy history, no concurrent chemotherapy history).
Exclusion criteria
Exclusion criteria: 1. Had other malignancies; 2. Patients who have received other drug tests in the past month; 3. Pregnant women or lactating women and treatment of contraception during the observation period of women of childbearing age; 4. Have a serious history of allergies or specific physical; 5. Have severe lung or heart disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cervical Cancer Mass; | — |
Countries
China
Contacts
Public ContactRan Li
Guizhou Cancer Hospital
Outcome results
None listed